Evaluation of an indirect immunofluorescence assay for detection of IgM (IF-IgM) type antibodies in the early diagnosis of leptospirosis

Authors

  • Paulina Meny Universidad de la República, Facultad de Medicina, Departamento de Bacteriología y Virología. Asistente interino
  • Elba Hernández Universidad de la República, Facultad de Medicina, Departamento de Bacteriología y Virología. Técnico especializado, titular
  • Felipe Schelotto Universidad de la República, Facultad de Medicina, Departamento de Bacteriología y Virología. Profesor Titular
  • Gustavo Varela Universidad de la República, Facultad de Medicina, Departamento de Bacteriología y Virología. Profesor Agregado

Keywords:

FLUORESCENT ANTIBODY TECHNIQUE, IMMUNOGLOBULIN M, LEPTOSPIROSIS

Abstract

Introduction: leptospirosis is a severe febrile disease, with a variety of clinical presentations. This results in the delay of clinical diagnosis, or in difficulties achieving it, so having the appropriate laboratory tests may deem useful to guide the initial care of these patients.
Objective: to evaluate a self-made immunofluorescence technique for the detection of IgM antibodies (IF-IgM) in the early diagnosis of leptospirosis.
Method: serum samples obtained from patients with a clinical suspicion of leptospirosis were analysed by IF-IgM antibodies and the microagglutination test (MAT) . Sensitivity and specificity of IF-IgM versus MAT were determined using a double entry table. Agreement between two observers was determined by the Kappa test.
Results: out of one hundred and sixty one early samples analysed, 97 serum samples corresponded to patients with a confirmed acute infection by MAT and 64 evidenced no infection. Sensitivity and specificity of IF-IgM assays in the acute phase were 79% and 100% respectively. The Kappa value was 1.
Conclusions: IF-IgM seems to be a useful tool for the early diagnosis of patients with leptospirosis. It does not need viable bacteria to be handled; it may be applied in laboratories equipped with ultraviolet light microscopes, a single serum sample is needed and the result is seen three to four hours later. As to its disadvantages, it fails to identify the involved serovars and a negative result does not discard infection. Bearing the latter into account, the MAT test is mandatory in a second serum sample obtained 10-20 days after the first one, to either discard or confirm the disease.

References

(1) Cerqueira GM, Picardeau M. A century of Leptospira strain typing. Infect Genet Evol 2009; 9(5):760-8.
(2) Adler B, de la Peña Moctezuma A. Leptospira and leptospirosis. Vet Microbiol 2010; 140(3-4):287-96.
(3) McBride AJ, Athanazio DA, Reis MG, Ko AI. Leptospirosis. Curr Opin Infect Dis 2005; 18(5):376-86.
(4) Levett PN. Leptospirosis. Clin Microbiol Rev 2001; 14(2):296-326.
(5) Agudelo Flórez P, Restrepo M, Lotero MA. Evaluación de la prueba de inmunofluorescencia indirecta para el diagnóstico de leptospirosis humana. Biomédica 2006; 26(2):216-23.
(6) Wuthiekanun V, Chierakul W, Limmathurotsakul D, Smythe LD, Symonds ML, Dohnt MF, et al. Optimization of culture of Leptospira from humans with leptospirosis. J Clin Microbiol 2007; 45(4):1363-5.
(7) Faine S, Adler B, Bolin C, Perolat P. Leptospira and leptospirosis. 2 ed. Melbourne, Australia: MediSci, 1999.
(8) Levett PN. Usefulness of serologic analysis as a predictor of the infecting serovar in patients with severe leptospirosis. Clin Infect Dis 2003; 36(4):447-52.
(9) Smits HL, Eapen CK, Sugathan S, Kuriakose M, Gasem MH, Yersin C, et al. Lateral-flow assay for rapid serodiagnosis of human leptospirosis. Clin Diagn Lab Immunol 2001; 8(1):166-9.
(10) Hull-Jackson C, Glass MB, Ari MD, Bragg SL, Branch SL, Whittington CU, et al. Evaluation of a commercial latex agglutination assay for serological diagnosis of leptospirosis. J Clin Microbiol 2006; 44(5):1853-5.
(11) Levett PN, Morey RE, Galloway RL, Turner DE, Steigerwalt AG, Mayer LW. Detection of pathogenic leptospires by real-time quantitative PCR. J Med Microbiol 2005; 54(Pt 1):45-9.
(12) Aricapa HJ, Pérez JE, Cabrera IC, Rivera K. Valoración de la respuesta de anticuerpos tipo IgM e IgG frente a leptospira en bovinos. Biosalud 2008; 7(1): 29-39.
(13) Schelotto F, Hernández E, González S, Del Monte A, Ifran S, Flores K, et al. Diez años de seguimiento de la leptospirosis humana en Uruguay: un problema de salud no resuelto. Rev Inst Med Trop S Paulo 2012; 54(2): 69-75.
(14) Appassakij H, Silpapojakul K, Wansit R, Woodtayakorn J. Evaluation of the immunofluorescent antibody test for the diagnosis of human leptospirosis. Am J Trop Med Hyg 1995; 52(4):340-3.
(15) Joshi S, Bal A, Bharadwaj R, Kumbhar R, Kagal A, Arjunwadkar V. Role of IgM specific indirect immunofluorescence assay in diagnosing an outbreak of leptospirosis. Indian J Pathol Microbiol 2002; 45(1):75-7.
(16) Pradutkanchana S, Pradutkanchana J, Khuntikij P. Detection of IgM specific antibody using indirect immunofluorescent assay for diagnosis of acute leptospirosis. J Med Assoc Thai 2003; 86(7):641-6.

Published

2014-06-30

How to Cite

1.
Meny P, Hernández E, Schelotto F, Varela G. Evaluation of an indirect immunofluorescence assay for detection of IgM (IF-IgM) type antibodies in the early diagnosis of leptospirosis. Rev. Méd. Urug. [Internet]. 2014 Jun. 30 [cited 2024 Sep. 7];30(2):88-92. Available from: https://revista.rmu.org.uy/index.php/rmu/article/view/247

Most read articles by the same author(s)